Cargando…
A rationale for targeting the P2X7 receptor in Coronavirus disease 19
Severe pneumonia which shares several of the features of acute respiratory distress syndrome (ARDS) is the main cause of morbidity and mortality in Coronavirus disease 19 (Covid‐19) for which there is no effective treatment, so far. ARDS is caused and sustained by an uncontrolled inflammatory activa...
Autores principales: | Di Virgilio, Francesco, Tang, Yong, Sarti, Alba Clara, Rossato, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280564/ https://www.ncbi.nlm.nih.gov/pubmed/32441783 http://dx.doi.org/10.1111/bph.15138 |
Ejemplares similares
-
Microglia P2X4 receptors as pharmacological targets for demyelinating diseases
por: Di Virgilio, Francesco, et al.
Publicado: (2018) -
Coronavirus disease and home recovery: a Singapore perspective
por: Tan, Hwee Yong Trevor, et al.
Publicado: (2023) -
P2X7: a receptor with a split personality that raises new hopes for anti-cancer therapy
por: Sarti, Alba Clara, et al.
Publicado: (2021) -
The P2X7 Receptor-Interleukin-1 Liaison
por: Giuliani, Anna Lisa, et al.
Publicado: (2017) -
Non-nucleotide Agonists Triggering P2X7 Receptor Activation and Pore Formation
por: Di Virgilio, Francesco, et al.
Publicado: (2018)